Compare MRAM & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRAM | ELUT |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.3M | 45.8M |
| IPO Year | 2016 | 2020 |
| Metric | MRAM | ELUT |
|---|---|---|
| Price | $9.50 | $1.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $6.00 |
| AVG Volume (30 Days) | ★ 284.2K | 128.9K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | ★ $49,417,000.00 | $12,293,000.00 |
| Revenue This Year | $10.22 | N/A |
| Revenue Next Year | $7.38 | $10.83 |
| P/E Ratio | ★ N/A | $1.34 |
| Revenue Growth | ★ 37.51 | N/A |
| 52 Week Low | $4.34 | $0.50 |
| 52 Week High | $17.24 | $2.74 |
| Indicator | MRAM | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 58.28 |
| Support Level | $8.50 | $0.86 |
| Resistance Level | $9.81 | $1.39 |
| Average True Range (ATR) | 0.54 | 0.07 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 76.60 | 88.89 |
Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.